MSCL.TO has been in the news recently: Bloom Burton & Co. Inc. exercised 3,200,000 warrants of Satellos Bioscience Inc., reducing its ownership stake to 8.0%. Satellos also reported encouraging Phase 1b trial results for SAT-3247, indicating potential grip strength improvements in five adult patients with Duchenne muscular dystrophy (DMD).
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
